Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF100.0.
  • Eventos
  • Noticias
  • Análisis
  • Cuenta
Industry Events
EnglishFrançaisEspañol中文العربية
EventosNoticiasAnálisisOrganizadores
Servicios
  • Marketing de EventosPublica, promociona y haz crecer tus eventos ante una audiencia B2B global.
  • Comunicado de PrensaDistribuye anuncios oficiales a profesionales del sector en todo el mundo.
  • Promoción de Ponentes y ExpertosMuestra tu experiencia y consigue keynotes, paneles y masterclasses.
Suscribirse
Acceso PonentesPublicar su evento gratis
  1. Inicio
  2. Noticias
  3. STAT+: Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more

STAT News

STAT+: Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more

Novartis and Bristol Myers Squibb have paused multiple cell therapy trials, while $480,000 has now become a routine price for a cancer drug. Read the latest pharma headlines in today's…

S

Por STAT News

1 September 2026|1 minuto de lectura
Compartir
Health Tech
STAT+: Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more
STAT+: Pharmalittle: We’re reading about Novartis and Bristol pausing cell therapy trials, a $480K cancer drug, and more
Compartir
← Volver a IE News

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

  • Opinion: Diabetes association CEO: What an independent review says happened at the ADA’s controversial June conference

    STAT News

    Opinion: Diabetes association CEO: What an independent review says happened at the ADA’s controversial June conference

    2 September 2026
  • Vaccines take center stage at federal autism advisory committee

    STAT News

    Vaccines take center stage at federal autism advisory committee

    28 August 2026
  • STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro

    STAT News

    STAT+: FDA clears Stryker’s ‘surgical cockpit’ that uses Apple’s VR headset, Vision Pro

    1 September 2026
  • Opinion: I’m a reproductive psychiatrist. The Lindsay Clancy trial will cause terrible damage to my field

    STAT News

    Opinion: I’m a reproductive psychiatrist. The Lindsay Clancy trial will cause terrible damage to my field

    1 September 2026
  • Opinion: The unintended consequences of the Lindsay Clancy case

    STAT News

    Opinion: The unintended consequences of the Lindsay Clancy case

    28 August 2026
  • STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more

    STAT News

    STAT+: Pharmalittle: We’re reading about an AstraZeneca trial failure, a ‘monstrous’ conflict of interest, and more

    28 August 2026

Perspectivas relacionadas

  • Advanced manufacturing and industrial AI

    Rare Earth Elements: The Invisible Engine of Modern Life

    11 Aug 202610 min read
  • Smart agriculture and food technology

    The Future of Food: Vertical & Indoor Farming Is Becoming a Serious Growth Industry

    Vertical farming cuts water use 90%, grows food anywhere, anytime—and with costs plummeting, it’s both a climate lifeline and a trillion-dollar investment bet.

    2 Aug 202610 min read
  • Precision medicine and longevity

    AI Series: Predictive HealthCare

    Predictive and Preventive medicine is quietly rewiring how care works. Here's what's changing, what's real, and how to get ahead of it.

    28 Jul 202614 min read
Browse all insights →

Eventos relacionados

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • ADIHEX 2026 (Abu Dhabi International Hunting and Equestrian Exhibition)

    28 Aug 2026
    Abu Dhabi, United Arab Emirates
  • Industrial Connect Expo

    31 Aug 2026
    India
  • Cinte Techtextil China 2026 (CTC26)

    1 Sept 2026
    China
Ver todos los eventos→

Más de la redacción

  • STAT+: 5 burning questions on Trump’s latest deals with drugmakers

    STAT+: 5 burning questions on Trump’s latest deals with drugmakers

    1 September 2026
  • Paxlovid did not help long Covid, study finds

    Paxlovid did not help long Covid, study finds

    1 September 2026
  • At a federal autism advisory committee meeting, members double down on long-debunked theories

    At a federal autism advisory committee meeting, members double down on long-debunked theories

    28 August 2026
  • STAT+: Up and down the ladder: The latest comings and goings

    STAT+: Up and down the ladder: The latest comings and goings

    28 August 2026
Industry Events

La plataforma de descubrimiento de eventos B2B más confiable del mundo. Conectamos a los profesionales del sector con las conferencias, exposiciones y cumbres que importan.

  • Industry Events
  • Noticias
  • Organizadores de eventos
  • Acerca de nosotros
  • Nuestros servicios
  • Organizador Premium
  • Event Pro
  • Conviértete en Ponente
  • Suscribirse
  • Términos
  • Privacidad

© 2026 Industry Events Worldwide. Todos los derechos reservados.

VF100.0.